We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$97.7B
AUM Growth
+$13.4B
Cap. Flow
+$8.11B
Cap. Flow %
8.3%
Top 10 Hldgs %
14.79%
Holding
11,408
New
1,114
Increased
4,572
Reduced
4,158
Closed
1,006

Sector Composition

Rank Sector Weight
1 Energy 9.1%
2 Healthcare 6.42%
3 Technology 5.93%
4 Financials 5.8%
5 Industrials 5.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVNTA
3751
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$687K ﹤0.01%
31,701
-656
-2% -$14.1K
INFA
3752
PUT
DELISTED
INFORMATICA CORP
INFA
$686K ﹤0.01%
17,600
-300
-2% -$11.4K
GLL icon
3753
ProShares UltraShort Gold
GLL
$127M
$683K ﹤0.01%
1,943
-1,744
-47% -$628K
COW
3754
DELISTED
iPath Bloomberg Livestock Subindex Total Return ETN due October 22, 2037
COW
$682K ﹤0.01%
24,662
-12,155
-33% -$330K
KW
3755
CALL
DELISTED
Kennedy-Wilson Holdings
KW
$681K ﹤0.01%
36,700
-8,600
-19% -$156K
NTGR icon
3756
NETGEAR
NTGR
$612M
$681K ﹤0.01%
22,047
+8,547
+63% +$262K
STP
3757
DELISTED
SUNTECH POWER HOLDINGS CO., LTD
STP
$681K ﹤0.01%
400,263
+68,115
+21% +$84.5K
NUGT icon
3758
CALL
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$840M
$679K ﹤0.01%
+338
New +$919K
CLX icon
3759
CALL
Clorox
CLX
$12B
$678K ﹤0.01%
8,300
-4,800
-37% -$405K
TARO
3760
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$678K ﹤0.01%
8,918
-172
-2% -$11.2K
LAMR icon
3761
CALL
Lamar Advertising Co
LAMR
$16.7B
$677K ﹤0.01%
14,400
+9,800
+213% +$432K
TJX icon
3762
CALL
TJX Companies
TJX
$179B
$677K ﹤0.01%
24,000
+4,400
+22% +$117K
XPRO icon
3763
Expro Ltd
XPRO
$1.64B
$677K ﹤0.01%
+3,773
New +$635K
KRFT
3764
CALL
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$677K ﹤0.01%
12,900
-13,100
-50% -$718K
ALE
3765
DELISTED
Allete
ALE
$674K ﹤0.01%
13,955
+7,338
+111% +$366K
ASNA
3766
CALL
DELISTED
Ascena Retail Group, Inc.
ASNA
$674K ﹤0.01%
1,690
+1,265
+298% +$450K
IQI icon
3767
Invesco Quality Municipal Securities
IQI
$526M
$673K ﹤0.01%
58,233
+7,511
+15% +$85.2K
QCOR
3768
PUT
DELISTED
QUESTCOR PHARMA INC
QCOR
$673K ﹤0.01%
11,600
-109,600
-90% -$6.51M
SRPT icon
3769
CALL
Sarepta Therapeutics
SRPT
$1.64B
$671K ﹤0.01%
14,200
+4,200
+42% +$162K
XLIS
3770
DELISTED
POWERSHARES S&P SMALLCAP INDUSTRIALS PORTFOLIO
XLIS
$671K ﹤0.01%
16,317
+12,565
+335% +$517K
WKC icon
3771
World Kinect Corp
WKC
$2.06B
$668K ﹤0.01%
17,890
-15,438
-46% -$595K
XCO
3772
PUT
DELISTED
Exco Resources
XCO
$668K ﹤0.01%
6,673
-7,569
-53% -$870K
BEN icon
3773
PUT
Franklin Resources
BEN
$16.8B
$667K ﹤0.01%
13,200
+11,400
+633% +$550K
CTBI icon
3774
Community Trust Bancorp
CTBI
$1.42B
$667K ﹤0.01%
18,085
-2,691
-13% -$95.8K
SWBI icon
3775
CALL
Smith & Wesson
SWBI
$649M
$667K ﹤0.01%
78,971
-30,573
-28% -$264K

Similar funds

UBS's Q3 2013 Portfolio in Review

As of Q3 2013, UBS held 11,408 positions worth $97.7B, up 16% from $84.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS deployed $8.11B of net new capital in Q3 2013, opening 1,114 new positions and adding to 4,572 existing holdings. Its largest new stake was COLE REAL ESTATE INVESTMENTS, INC COM: 11,625,569 shares worth $143M.

By sector, the portfolio is most concentrated in Energy at 9.1% of assets, down from 9.5% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Nuance Communications, Inc., an estimated $308M trimmed.

  • UBS's largest Q3 2013 buy was COLE REAL ESTATE INVESTMENTS, INC COM: 11,625,569 shares worth $143M.
  • UBS added most to Mastercard in Q3 2013, an estimated $185M increase.
  • UBS's biggest Q3 2013 reduction was Nuance Communications, Inc., cutting an estimated $308M.
  • UBS fully exited THE NEWS CORPORATION LTD CL-B in Q3 2013, selling an estimated $30.8M.
  • UBS's ten largest holdings make up 15% of its $97.7B portfolio in Q3 2013.
  • UBS opened 1,114 new positions and closed 1,006 in Q3 2013.
  • UBS's portfolio value rose 16% quarter-over-quarter to $97.7B.

Based on UBS's 13F filing for Q3 2013, filed 13 Nov 2013.